▲ SIGMATERMINAL Open Terminal →

Analyses / RGTI

RGTI Rigetti Computing Inc As of Sep 10, 2026
$15.24

Early-stage quantum computing hardware vendor; cash-rich but unprofitable; high volatility and insider selling pressure.

Setup: speculative Confidence: 35 Horizon: 6-12 months Risk: very high Category: small-cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals RGTI's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Quantum computing TAM expanding; CHIPS Act funding may accelerate adoption; current cash position ($17.25 current ratio) funds runway; potential for 2-3x if commercialization inflects or strategic partnership materializes.

▼ Bear Case

Revenue declining (-18.5% YoY); net margin at -3050%, operating margin -1194%; massive cash burn; P/S of 717x indicates extreme early-stage valuation risk; insider selling 1.85x buys; 73% drawdown from 52-week high suggests momentum collapse; competitive pressure from IonQ, D-Wave.

Valuation

OVERVALUED (on traditional metrics) / UNVALUED (on fundamentals) — score 25/100

RGTI trades on speculative TAM and CHIPS Act tailwinds, not current profitability. P/S 717x, P/B 29.1x are extreme for any operating company. No meaningful earnings power yet. Valuation hinges entirely on quantum commercialization path and capital-raise ability.

Technical Levels

Support · $12.53 (52-week low; cash/carry floor) · $14.00 (Recent intraday support) · $15.15 (Today's intraday low)

Resistance · $15.94 (Today's intraday high) · $17.50 (200-day MA (approx)) · $20.00 (Psychological / pre-earnings level) · $58.15 (52-week high; massive resistance)

Financial Health

Score 60/100. Rigetti has ample liquidity (current & quick ratios >16), implying strong cash position relative to current liabilities. However, massive operating losses mean capital burn is the material risk, not insolvency in next 12 months. If revenue does not materially improve or capital raise needed, dilution will pressure stock. Debt-to-equity data unavailable.

Catalysts

CHIPS Act funding awards / partnership announcementsNext 6–12 monthshigh
Major customer announcement or trial deployment12–18 monthshigh
Capital raise (equity or debt)Possible 12–24 months if cash burn accelerateshigh (likely dilutive)
Quarterly earnings misses or guidance cutsAny quartermedium (high volatility stock may rally/dump on sentiment swings)
M&A / strategic acquisition by larger semiconductor or defense playerSpeculative; 1–3 yearsvery high (binary outcome)

Risk Flags

No P/E or forward P/E available; company unprofitable with >3000% net margin loss.
P/S ratio of 717x is extreme; indicates zero current profit visibility; typical SaaS 5-10x, biotech pre-revenue 50-200x.
Revenue declining 18.5% YoY; earliest signals of market traction not yet evident from top-line.
Insider selling 2.45M shares vs 1.32M bought (1.85:1 ratio) — meaningful accumulation by insiders NOT observed.
Beta 2.11; stock is 2x+ as volatile as market; expect sharp swings on sector sentiment, rate changes.
52-week range $12.53–$58.15 reflects 364% volatility; no near-term catalyst disclosed.
Market cap only $5.1B; low institutional float may amplify price swings.
Quantum computing remains unproven commercial application; TAM estimates highly speculative.

See RGTI's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock RGTI free →

Recent News

More Analyses

RGTI FAQ

Is RGTI a buy right now?

Rigetti Computing Inc's current read is a speculative setup with 35 confidence over a 6-12 months horizon. Valuation: OVERVALUED (on traditional metrics) / UNVALUED (on fundamentals). See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is RGTI overvalued?

OVERVALUED (on traditional metrics) / UNVALUED (on fundamentals) (valuation score 25/100). RGTI trades on speculative TAM and CHIPS Act tailwinds, not current profitability. P/S 717x, P/B 29.1x are extreme for any operating company. No meaningful earnings power yet. Valuation hinges entirely on quantum commercialization path and capital-raise ability.

What are the risks of buying RGTI?

Revenue declining (-18.5% YoY); net margin at -3050%, operating margin -1194%; massive cash burn; P/S of 717x indicates extreme early-stage valuation risk; insider selling 1.85x buys; 73% drawdown from 52-week high suggests momentum collapse; competitive pressure from IonQ, D-Wave.